Sutro Biopharma (STRO) EBT Margin Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - | -175,649.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -175,649.00 |
| Sep 30, 2025 | -1,396.00 |
| Jun 30, 2025 | 25,165.00 |
| Mar 31, 2025 | -69,854.00 |
| Dec 31, 2024 | 100,551.00 |
| Sep 30, 2024 | -29,228.00 |
| Jun 30, 2024 | 9,883.00 |
| Mar 31, 2024 | -5,573.00 |
| Dec 31, 2023 | 44,198.00 |
| Sep 30, 2023 | -20,285.00 |
| Jun 30, 2023 | -28,486.00 |
| Mar 31, 2023 | 27,143.00 |
| Dec 31, 2022 | -4,292.00 |
| Sep 30, 2022 | 28,533.00 |
| Jun 30, 2022 | -6,175.00 |
| Mar 31, 2022 | -52,904.00 |
| Dec 31, 2021 | -2,098.00 |
| Sep 30, 2021 | -29,191.00 |
| Jun 30, 2021 | 17,859.00 |
| Mar 31, 2021 | 13,980.00 |
| Dec 31, 2020 | -20,605.00 |
| Sep 30, 2020 | 3,426.00 |
| Jun 30, 2020 | -6,948.00 |
| Mar 31, 2020 | -8,177.00 |
| Dec 31, 2019 | -12,300.00 |
| Sep 30, 2019 | 2,547.00 |
| Jun 30, 2019 | 7,128.00 |
| Mar 31, 2019 | 1,573.00 |
| Dec 31, 2018 | 37,495.00 |
| Sep 30, 2018 | -12,357.00 |